Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Oct 13;387(15):1373-1384.
doi: 10.1056/NEJMoa2207576.

Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion

Tudor G Jovin  1 , Chuanhui Li  1 , Longfei Wu  1 , Chuanjie Wu  1 , Jian Chen  1 , Changchun Jiang  1 , Zhonghua Shi  1 , Zongen Gao  1 , Cunfeng Song  1 , Wenhuo Chen  1 , Ya Peng  1 , Chen Yao  1 , Ming Wei  1 , Tong Li  1 , Liping Wei  1 , Guodong Xiao  1 , Hua Yang  1 , Ming Ren  1 , Jiangang Duan  1 , Xinfeng Liu  1 , Qingwu Yang  1 , Yuxiu Liu  1 , Qingfeng Zhu  1 , Wanchao Shi  1 , Qiyi Zhu  1 , Xiaobo Li  1 , Zaiyu Guo  1 , Qi Yang  1 , Chengbei Hou  1 , Wenbo Zhao  1 , Qingfeng Ma  1 , Yunzhou Zhang  1 , Liqun Jiao  1 , Hongqi Zhang  1 , David S Liebeskind  1 , Hui Liang  1 , Ashutosh P Jadhav  1 , Changming Wen  1 , Scott Brown  1 , Liangfu Zhu  1 , Huawei Ye  1 , Marc Ribo  1 , Mingze Chang  1 , Haiqing Song  1 , Jun Chen  1 , Xunming Ji  1 ; BAOCHE Investigators
Collaborators, Affiliations
Randomized Controlled Trial

Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion

Tudor G Jovin et al. N Engl J Med. .

Abstract

Background: The effects and risks of endovascular thrombectomy 6 to 24 hours after stroke onset due to basilar-artery occlusion have not been extensively studied.

Methods: In a trial conducted over a 5-year period in China, we randomly assigned, in a 1:1 ratio, patients with basilar-artery stroke who presented between 6 to 24 hours after symptom onset to receive either medical therapy plus thrombectomy or medical therapy only (control). The original primary outcome, a score of 0 to 4 on the modified Rankin scale (range, 0 to 6, with a score of 0 indicating no disability, 4 moderately severe disability, and 6 death) at 90 days, was changed to a good functional status (a modified Rankin scale score of 0 to 3, with a score of 3 indicating moderate disability). Primary safety outcomes were symptomatic intracranial hemorrhage at 24 hours and 90-day mortality.

Results: A total of 217 patients (110 in the thrombectomy group and 107 in the control group) were included in the analysis; randomization occurred at a median of 663 minutes after symptom onset. Enrollment was halted at a prespecified interim analysis because of the superiority of thrombectomy. Thrombolysis was used in 14% of the patients in the thrombectomy group and in 21% of those in the control group. A modified Rankin scale score of 0 to 3 (primary outcome) occurred in 51 patients (46%) in the thrombectomy group and in 26 (24%) in the control group (adjusted rate ratio, 1.81; 95% confidence interval [CI], 1.26 to 2.60; P<0.001). The results for the original primary outcome of a modified Rankin scale score of 0 to 4 were 55% and 43%, respectively (adjusted rate ratio, 1.21; 95% CI, 0.95 to 1.54). Symptomatic intracranial hemorrhage occurred in 6 of 102 patients (6%) in the thrombectomy group and in 1 of 88 (1%) in the control group (risk ratio, 5.18; 95% CI, 0.64 to 42.18). Mortality at 90 days was 31% in the thrombectomy group and 42% in the control group (adjusted risk ratio, 0.75; 95% CI, 0.54 to 1.04). Procedural complications occurred in 11% of the patients who underwent thrombectomy.

Conclusions: Among patients with stroke due to basilar-artery occlusion who presented 6 to 24 hours after symptom onset, thrombectomy led to a higher percentage with good functional status at 90 days than medical therapy but was associated with procedural complications and more cerebral hemorrhages. (Funded by the Chinese National Ministry of Science and Technology; BAOCHE ClinicalTrials.gov number, NCT02737189.).

PubMed Disclaimer

Comment in

Similar articles

  • Trial of Endovascular Treatment of Acute Basilar-Artery Occlusion.
    Tao C, Nogueira RG, Zhu Y, Sun J, Han H, Yuan G, Wen C, Zhou P, Chen W, Zeng G, Li Y, Ma Z, Yu C, Su J, Zhou Z, Chen Z, Liao G, Sun Y, Ren Y, Zhang H, Chen J, Yue X, Xiao G, Wang L, Liu R, Liu W, Liu Y, Wang L, Zhang C, Liu T, Song J, Li R, Xu P, Yin Y, Wang G, Baxter B, Qureshi AI, Liu X, Hu W; ATTENTION Investigators. Tao C, et al. N Engl J Med. 2022 Oct 13;387(15):1361-1372. doi: 10.1056/NEJMoa2206317. N Engl J Med. 2022. PMID: 36239644 Clinical Trial.
  • Endovascular Therapy for Stroke Due to Basilar-Artery Occlusion.
    Langezaal LCM, van der Hoeven EJRJ, Mont'Alverne FJA, de Carvalho JJF, Lima FO, Dippel DWJ, van der Lugt A, Lo RTH, Boiten J, Lycklama À Nijeholt GJ, Staals J, van Zwam WH, Nederkoorn PJ, Majoie CBLM, Gerber JC, Mazighi M, Piotin M, Zini A, Vallone S, Hofmeijer J, Martins SO, Nolte CH, Szabo K, Dias FA, Abud DG, Wermer MJH, Remmers MJM, Schneider H, Rueckert CM, de Laat KF, Yoo AJ, van Doormaal PJ, van Es ACGM, Emmer BJ, Michel P, Puetz V, Audebert HJ, Pontes-Neto OM, Vos JA, Kappelle LJ, Algra A, Schonewille WJ; BASICS Study Group. Langezaal LCM, et al. N Engl J Med. 2021 May 20;384(20):1910-1920. doi: 10.1056/NEJMoa2030297. N Engl J Med. 2021. PMID: 34010530 Clinical Trial.
  • Trial of Endovascular Therapy for Acute Ischemic Stroke with Large Infarct.
    Huo X, Ma G, Tong X, Zhang X, Pan Y, Nguyen TN, Yuan G, Han H, Chen W, Wei M, Zhang J, Zhou Z, Yao X, Wang G, Song W, Cai X, Nan G, Li D, Wang AY, Ling W, Cai C, Wen C, Wang E, Zhang L, Jiang C, Liu Y, Liao G, Chen X, Li T, Liu S, Li J, Gao F, Ma N, Mo D, Song L, Sun X, Li X, Deng Y, Luo G, Lv M, He H, Liu A, Zhang J, Mu S, Liu L, Jing J, Nie X, Ding Z, Du W, Zhao X, Yang P, Liu L, Wang Y, Liebeskind DS, Pereira VM, Ren Z, Wang Y, Miao Z; ANGEL-ASPECT Investigators. Huo X, et al. N Engl J Med. 2023 Apr 6;388(14):1272-1283. doi: 10.1056/NEJMoa2213379. Epub 2023 Feb 10. N Engl J Med. 2023. PMID: 36762852 Clinical Trial.
  • Endovascular thrombectomy for basilar artery occlusion: translating research findings into clinical practice.
    Alemseged F, Nguyen TN, Coutts SB, Cordonnier C, Schonewille WJ, Campbell BCV. Alemseged F, et al. Lancet Neurol. 2023 Apr;22(4):330-337. doi: 10.1016/S1474-4422(22)00483-5. Epub 2023 Feb 10. Lancet Neurol. 2023. PMID: 36780915 Review.
  • Endovascular thrombectomy after acute ischemic stroke of the basilar artery: a meta-analysis of four randomized controlled trials.
    Adusumilli G, Kobeissi H, Ghozy S, Hardy N, Kallmes KM, Hutchison K, Kallmes DF, Brinjikji W, Albers GW, Heit JJ. Adusumilli G, et al. J Neurointerv Surg. 2023 Dec 21;15(e3):e446-e451. doi: 10.1136/jnis-2022-019776. J Neurointerv Surg. 2023. PMID: 36597942 Review.
See all similar articles

Cited by

See all "Cited by" articles

Publication types

MeSH terms

Substances

Associated data

LinkOut - more resources